🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesAdiponectin and leptin changes on GLP-1 therapy — what worked for you? Page 6

Adiponectin and leptin changes on GLP-1 therapy — what worked for you?

bri_stats Mon, Dec 15, 2025 at 5:59 AM 39 replies 1,546 viewsPage 6 of 8
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Dec 21, 2025 at 9:20 AM#26
DataDave said:
Practical: whatever you change, write down the date and the reason.

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

8 6AttorneyGrant, DebRD_ATL, KristenIndy and 5 others
Reply Quote Save Share Report
SkepticalSean
Member
98
345
Jan 2025
Maine
Dec 22, 2025 at 1:39 AM#27
DataDave said:
Practical: whatever you change, write down the date and the reason.

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

9 7paige_pharma, emma_london, tammy_FL and 6 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Dec 22, 2025 at 5:58 PM#28

Clinical perspective, offered as context rather than as advice. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

10 8PharmD_Rodriguez, julia.endo, JessicaM_2024 and 7 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Dec 23, 2025 at 10:16 AM#29
andrew_nyc said:
The version of this that has an answer is narrower than the version being asked.

This matches mine closely enough to be worth saying so out loud. The detail I would add is minor and it is already implied above.

Last edited: Dec 23, 2025 at 4:16 PM
11 9Dr.PainCLE, mike_mealprep, NicoleRaleigh and 8 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Dec 24, 2025 at 2:34 AM#30

Reporting back.

Update: I got the sleep and the intake sorted before deciding it was the drug, and most of the flatness went with them. Not all of it, and I am watching the rest.

33 6julia.endo, JessicaM_2024, TomFromTexas and 30 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register